Recombinant CD19 (Loncastuximab Biosimilar) antibody

Catalog No. ABIN7597795

The Chimeric Chimeric anti-CD19 (Loncastuximab Biosimilar) antibody is suitable to detect CD19 (Loncastuximab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD19 (Loncastuximab Biosimilar) antibody (ABIN7597795)

Target: CD19 (Loncastuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Loncastuximab Biosimilar Antibody

Specificity: CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4.55 mg/mL

Buffer: 9 mM Citric acid monohydrat, 41 mM Na2HPO4, 1 % mannitol, 5 % trehalose, 0.02 % Tween20, pH 6.5

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: CD19 (Loncastuximab Biosimilar)

Alternative Name: Loncastuximab Biosimilar

Target Type: Biosimilar

Background: CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4

UniProt: P15391

CAS-No: 1875032-68-0